Capricor Therapeutics
Develops deramiocel for Duchenne muscular dystrophy and StealthX exosome therapies.
$9.64
After-hours close+0.04 (+0.41%)
At close$9.60(−4.57%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 58.82%33.83M sharesInsiders 0.88%504.8K sharesOther 40.30%23.18M shares
Shares outstanding 57.51M · Float 48.21M · 83.8% free float
Institutions13F, as of Mar 31, 2026
195 holders · 33.83M shares · 69 new positions · 129 increased · 37 reduced · 27 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Suvretta Capital Management, LLC | 3.82M | 6.64% | +2.03M | May 15, 2026 |
| BlackRock, Inc. | 3.42M | 5.95% | +570.8K | May 13, 2026 |
| Tang Capital Management LLC | 3.40M | 5.91% | +1.70M | May 15, 2026 |
| State Street Corp | 2.18M | 3.79% | +1.35M | May 15, 2026 |
| Vanguard Capital Management LLC | 2.03M | 3.53% | +2.03Mnew | May 15, 2026 |
| Ra Capital Management, L.P. | 1.51M | 2.62% | 0 | May 15, 2026 |
| Geode Capital Management, LLC | 1.12M | 1.94% | +101.0K | May 15, 2026 |
| Goldman Sachs Group Inc | 912.0K | 1.59% | +464.0K | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Suvretta Capital Management, LLC | 6.60% | 3.42M | 13G | Feb 26, 2026 ↗ |
| Tang Capital Management, LLC | 6.60% | 3.40M | 13G | Jan 26, 2026 ↗ |
| BlackRock, Inc. | 6.50% | 2.97M | 13G | Feb 5, 2025 ↗ |
| RA Capital Management, L.P. | 5.20% | 3.01M | 13G | Aug 3, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Linda Marban | director, officer: CHIEF EXECUTIVE OFFICER | 211.1K | 0.37% | Mar 5, 2025 |
| Frank Litvack | director | 180.1K | 0.31% | May 14, 2026 |
| Earl M. Jr Collier | director | 57.6K | 0.10% | Feb 28, 2025 |
| Karen Krasney | officer: EVP, GENERAL COUNSEL | 30.5K | 0.05% | Jun 29, 2026 |
| George W. Jr Dunbar | director | 14.3K | 0.02% | Dec 23, 2025 |
| Anthony Bergmann | officer: CHIEF FINANCIAL OFFICER | 11.2K | 0.02% | Jun 29, 2026 |
6 ten-percent owners hold 7.60M shares by Form 4, outside the officers-and-directors figure above · 17 people have not refiled in the last 18 months (168.0K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 25, 2026 | Anthony Bergmannofficer: CHIEF FINANCIAL OFFICER | Sale | 24,100 | $30.38 | 11,223 |
| Jun 25, 2026 | Karen Krasneyofficer: EVP, GENERAL COUNSEL | Sale | 24,100 | $30.38 | 30,547 |
| Jun 24, 2026 | Anthony Bergmannofficer: CHIEF FINANCIAL OFFICER | Sale | 400 | $30.00 | 11,223 |
| Jun 24, 2026 | Karen Krasneyofficer: EVP, GENERAL COUNSEL | Sale | 400 | $30.00 | 30,547 |
| May 1, 2026 | Anthony Bergmannofficer: CHIEF FINANCIAL OFFICER | Sale | 25,000 | $31.70 | 8,223 |
| May 1, 2026 | Karen Krasneyofficer: EVP, GENERAL COUNSEL | Sale | 25,000 | $31.70 | 30,547 |
| Apr 2, 2026 | Karimah Es Sabardirector | Sale | 7,529 | $32.00 | 0 |
| Mar 31, 2026 | Anthony Bergmannofficer: CHIEF FINANCIAL OFFICER | Sale | 25,000 | $30.13 | 8,223 |
| Apr 1, 2026 | Karimah Es Sabardirector | Sale | 53,735 | $31.03 | 0 |
| Mar 31, 2026 | Karimah Es Sabardirector | Sale | 61,265 | $30.17 | 0 |
CongressHouse and Senate disclosures
Not reported.